{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T23:14:45Z","timestamp":1783379685665,"version":"3.54.6"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013739","name":"Pfizer Canada ULC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.vaccine.2026.128351","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:56:38Z","timestamp":1772643398000},"page":"128351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Prevalence of and risk factors for antimicrobial resistance in pneumococcal disease in southern Ontario during the PCV13 era"],"prefix":"10.1016","volume":"78","author":[{"given":"Altynay","family":"Shigayeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda L.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa R.","family":"Golden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Zhanel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne L.","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Kandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigmund","family":"Krajden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Lovinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystyna","family":"Ostrowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Rau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ricciuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie","family":"Vermeiren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna","family":"Faheem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna","family":"Farooqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazi","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel X.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Nayani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mare","family":"Pejkovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agron","family":"Plevneshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asfia","family":"Sultana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Vikulova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"McGeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128351_bb0005","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/S2214-109X(18)30408-X","article-title":"Global, regional, and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015: a systematic analysis","volume":"7","author":"McAllister","year":"2019","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2026.128351_bb0010","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1007\/s12325-020-01248-7","article-title":"Burden of community-acquired pneumonia and unmet clinical needs","volume":"37","author":"Ferreira-Coimbra","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.vaccine.2026.128351_bb0015","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13054-020-03442-z","article-title":"Burden of pneumococcal pneumonia requiring ICU admission in France: 1-year prognosis, resources use, and costs","volume":"25","author":"Dupuis","year":"2021","journal-title":"Crit Care"},{"key":"10.1016\/j.vaccine.2026.128351_bb0020","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1128\/CMR.00058-15","article-title":"Biological and epidemiological features of antibiotic-resistant Streptococcus pneumoniae in pre- and post-conjugate vaccine eras: a United States perspective","volume":"29","author":"Kim","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2026.128351_bb0025","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3201\/eid0803.010192","article-title":"A European study on the relationship between antimicrobial use and antimicrobial resistance","volume":"8","author":"Bronzwaer","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128351_bb0030","doi-asserted-by":"crossref","unstructured":"Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A, et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. NEnglJMed 2006;354:1455\u201363. doi:https:\/\/doi.org\/10.1056\/NEJMoa051642, N Engl J Med.","DOI":"10.1056\/NEJMoa051642"},{"key":"10.1016\/j.vaccine.2026.128351_bb0035","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1473-3099(19)30297-X","article-title":"Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study","volume":"19","author":"Lo","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128351_bb0040","doi-asserted-by":"crossref","unstructured":"Davies NG, Flasche S, Jit M, Atkins KE. Modeling the effect of vaccination on selection for antibiotic resistance in Streptococcus pneumoniae. Sci Transl Med 2021;13. doi:https:\/\/doi.org\/10.1126\/scitranslmed.aaz8690.","DOI":"10.1126\/scitranslmed.aaz8690"},{"key":"10.1016\/j.vaccine.2026.128351_bb0045","doi-asserted-by":"crossref","unstructured":"Yildirim I, Lapidot R, Shaik-Dasthagirisaheb YB, Hinderstein S, Lee H, Klevens M, et al. Invasive pneumococcal disease after 2 decades of pneumococcal conjugate vaccine use. Pediatrics 2024;153(1):e2023063039. doi:https:\/\/doi.org\/10.1542\/peds.2023-063039.","DOI":"10.1542\/peds.2023-063039"},{"key":"10.1016\/j.vaccine.2026.128351_bb0050","doi-asserted-by":"crossref","unstructured":"Tomczyk S, Lynfield R, Schaffner W, Reingold A, Miller L, Petit S, et al. Prevention of antibiotic-nonsusceptible invasive pneumococcal disease with the 13-valent pneumococcal conjugate vaccine. Clin Infect Dis 2016;62:1119\u201325. doi:https:\/\/doi.org\/10.1093\/cid\/ciw067.","DOI":"10.1093\/cid\/ciw067"},{"key":"10.1016\/j.vaccine.2026.128351_bb0055","unstructured":"StatisticsCanada. Statistics Canada. Table 17-10-0142-01 Population estimates, July 1, by census subdivision, 2021 boundaries, 2025. Available at: https:\/\/www150.statcan.gc.ca\/t1\/tbl1\/en\/tv.action?pid=1710013901. [Accessed 20August2025]."},{"key":"10.1016\/j.vaccine.2026.128351_bb0060","doi-asserted-by":"crossref","first-page":"5863","DOI":"10.1016\/j.vaccine.2013.09.049","article-title":"Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995-2011","volume":"31","author":"Rudnick","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128351_bb0065","unstructured":"The Ontario Immunization Advisory Committee (OIAC). Recommendation for the Routine Pediatric Pneumococcal Immunization Program, 2024, Public Health Ontario: Ontario, Canada. Available at: https:\/\/www.publichealthontario.ca\/-\/media\/Documents\/O\/24\/oiac-routine-pediatric-pneumococcal-immunization-program.pdf. [Accessed 20August2025]."},{"key":"10.1016\/j.vaccine.2026.128351_bb0070","unstructured":"The Ontario Immunization Advisory Committee (OIAC). Recommendations: New Health Canada Authorized Pneumococcal Conjugate Vaccines for Adults Aged \u226518 Years, 2024, Public Health Ontario: Ontario, Canada. Available at: https:\/\/www.publichealthontario.ca\/-\/media\/Documents\/O\/25\/oiac-recommendations-pneumococcal-immunization-adults-pcv21.pdf?rev=44a9fc8f6a3d4b809e424f9c0e43b173&sc_lang=en. [Accessed 20August22025]."},{"key":"10.1016\/j.vaccine.2026.128351_bb0075","unstructured":"Public Health Agency of Canada. Adult National Immunization Coverage Survey (aNICS): 2023 results. Available at: https:\/\/www.canada.ca\/en\/public-health\/services\/immunization-vaccines\/vaccination-coverage\/adult-national-immunization-coverage-survey-2023-results.html. [Accessed 7January2026]."},{"key":"10.1016\/j.vaccine.2026.128351_bb0080","unstructured":"Public Health Ontario. Immunization Data Tool. Available at: https:\/\/www.publichealthontario.ca\/en\/Data-and-Analysis\/Infectious-Disease\/Immunization-Tool. [Accessed 7January2026]."},{"key":"10.1016\/j.vaccine.2026.128351_bb0085","series-title":"Manual of clinical microbiology, 10th Edition","first-page":"405","author":"Spellerberg","year":"2011"},{"key":"10.1016\/j.vaccine.2026.128351_bb0090","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1128\/JCM.42.6.2518-2522.2004","article-title":"Simple, rapid latex agglutination test for serotyping of pneumococci (Pneumotest-latex)","volume":"42","author":"Slotved","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2026.128351_bb0095","first-page":"699","article-title":"The quellung reaction, a neglected microbiologic technique","volume":"43","author":"Austrian","year":"1976","journal-title":"Mt Sinai J Med"},{"key":"10.1016\/j.vaccine.2026.128351_bb0100","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.1016\/j.vaccine.2021.08.061","article-title":"Whole genome characterization of Streptococcus pneumoniae from respiratory and blood cultures collected from Canadian hospitals before and after PCV-13 implementation in Canada: focus on serotypes 22F and 33F from CANWARD 2007-2018","volume":"39","author":"Golden","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128351_bb0105","unstructured":"Clinical and laboratory standards institute. Performance standards for antimicrobial susceptibility testing. 34th ed. CLSI Standard M100. Clinical Laboratory and Standards Institute, Wayne, PA 2025."},{"key":"10.1016\/j.vaccine.2026.128351_bb0110","unstructured":"Clinical laboratory and standards institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 12th Edition. CLSI standard M07. Clinical laboratory and standards institute. Wayne, PA 2024."},{"key":"10.1016\/j.vaccine.2026.128351_bb0115","doi-asserted-by":"crossref","first-page":"121","DOI":"10.14745\/ccdr.v50i05a02","article-title":"Invasive pneumococcal disease surveillance in Canada, 2021-2022","volume":"50","author":"Griffith","year":"2024","journal-title":"Can Commun Dis Rep"},{"key":"10.1016\/j.vaccine.2026.128351_bb0120","doi-asserted-by":"crossref","unstructured":"Musher DM, Alexandraki I, Graviss EA, Yanbeiy N, Eid A, Inderias LA, et al. Bacteremic and nonbacteremic pneumococcal pneumonia. A prospective study Medicine (Baltimore) 2000;79:210\u201321. doi:https:\/\/doi.org\/10.1097\/00005792-200007000-00002.","DOI":"10.1097\/00005792-200007000-00002"},{"key":"10.1016\/j.vaccine.2026.128351_bb0125","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.vaccine.2015.11.021","article-title":"Association of serotype with respiratory presentations of pneumococcal infection, Ontario, Canada, 2003-2011","volume":"34","author":"Shigayeva","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128351_bb0130","unstructured":"The National Advisory Committee on Immunization (NACI). Pneumococcal vaccines. In: The Canadian Immunization Guide, part 4, The Public Health Agency of Canada (PHAC), Ottawa, Canada, 2024. Available at: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-4-active-vaccines\/page-16-pneumococcal-vaccine.html. [Accessed 20August 2025."},{"key":"10.1016\/j.vaccine.2026.128351_bb0135","doi-asserted-by":"crossref","unstructured":"Shigayeva A, Rudnick W, Green K, Chen DK, Demczuk W, Gold WL, et al. Invasive pneumococcal disease among immunocompromised persons: implications for vaccination programs. Clin Infect Dis 2016;62:139\u201347. doi:https:\/\/doi.org\/10.1093\/cid\/civ803.","DOI":"10.1093\/cid\/civ803"},{"key":"10.1016\/j.vaccine.2026.128351_bb0140","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care associated infection and criteria for specific types of infections in the acute care setting","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.vaccine.2026.128351_bb0145","unstructured":"Ontario Ministry of Health. Ontario's routine Immunization Schedule. Available at: https:\/\/www.ontario.ca\/page\/ontarios-routine-immunization-schedule. Last updated 14July2025. [Accessed 20August2025]."},{"key":"10.1016\/j.vaccine.2026.128351_bb0150","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1128\/IAI.71.11.6192-6198.2003","article-title":"Genetic basis for the structural difference between Streptococcus pneumoniae serotype 15B and 15C capsular polysaccharides","volume":"71","author":"Van Selm","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2026.128351_bb0155","doi-asserted-by":"crossref","unstructured":"Grant LR, Hanquet G, Sepulveda-Pachon IT, Theilacker C, Baay M, Slack MPE, et al. Effects of PCV10 and PCV13 on pneumococcal serotype 6C disease, carriage, and antimicrobial resistance. Vaccine 2024;42:2983\u201393. doi:https:\/\/doi.org\/10.1016\/j.vaccine.2024.03.065.","DOI":"10.1016\/j.vaccine.2024.03.065"},{"key":"10.1016\/j.vaccine.2026.128351_bb0160","unstructured":"Dekker J. MR. COVID-19 restrictions index update. Economic and Social Reports, Statistics Canada 30. Available at: https:\/\/www150.statcan.gc.ca\/n1\/pub\/36-28-0001\/2022008\/article\/00002-eng.htm. Released 24August2022. [Accessed 20August 2025]. 2022."},{"key":"10.1016\/j.vaccine.2026.128351_bb0165","doi-asserted-by":"crossref","unstructured":"Shaw D, Abad R, Amin-Chowdhury Z, Bautista A, Bennett D, Broughton K, et al. Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS consortium. Lancet Digit Health 2023;5:e582-e93. doi:https:\/\/doi.org\/10.1016\/S2589-7500(23)00108-5.","DOI":"10.1016\/S2589-7500(23)00108-5"},{"key":"10.1016\/j.vaccine.2026.128351_bb0170","article-title":"Invasive pneumococcal infections in France: changes from 2009 to 2021 in antibiotic resistance and serotype distribution of Streptococcus pneumoniae based on data from the French regional pneumococcal observatories network","volume":"53","author":"Plainvert","year":"2023","journal-title":"Infect Dis Now"},{"key":"10.1016\/j.vaccine.2026.128351_bb0175","doi-asserted-by":"crossref","unstructured":"Savrasova L, Villerusa A, Zeltina I, Krumina A, Cupeca H, Balasegaram S, et al. Streptococcus pneumoniae serotypes and factors associated with antimicrobial resistance in invasive pneumococcal disease cases in Latvia, 2012-2022. Front Public Health 2025;13:1501821. doi:https:\/\/doi.org\/10.3389\/fpubh.2025.1501821.","DOI":"10.3389\/fpubh.2025.1501821"},{"key":"10.1016\/j.vaccine.2026.128351_bb0180","doi-asserted-by":"crossref","first-page":"10195","DOI":"10.1007\/s00210-025-03887-5","article-title":"Most European countries will miss EU targets on antibacterial use by 2030: historical analysis of European and OECD countries, comparison of community and hospital sectors and forecast to 2040","volume":"398","author":"Bindel","year":"2025","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.vaccine.2026.128351_bb0185","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00430-024-00797-w","article-title":"Serotype distribution, antibiotic resistance, multilocus sequence typing, and virulence factors of invasive and non-invasive Streptococcus pneumoniae in Northeast China from 2000 to 2021","volume":"213","author":"Xu","year":"2024","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2026.128351_bb0190","doi-asserted-by":"crossref","unstructured":"Passaris I, Depickere S, Braeye T, Mukovnikova M, Vodolazkaia A, Abels C, et al. Non-invasive Streptococcus pneumoniae infections are associated with different serotypes than invasive infections, Belgium, 2020 to 2023. Euro Surveill 2024;29:2400108. doi:https:\/\/doi.org\/10.2807\/1560-7917.ES.2024.29.45.2400108.","DOI":"10.2807\/1560-7917.ES.2024.29.45.2400108"},{"key":"10.1016\/j.vaccine.2026.128351_bb0195","doi-asserted-by":"crossref","unstructured":"Higgs C, Kumar LS, Stevens K, Strachan J, Korman T, Horan K, et al. Comparison of contemporary invasive and non-invasive Streptococcus pneumoniae isolates reveals new insights into circulating anti-microbial resistance determinants. Antimicrob Agents Chemother 2023;67:e0078523. doi:https:\/\/doi.org\/10.1128\/aac.00785-23.","DOI":"10.1128\/aac.00785-23"},{"key":"10.1016\/j.vaccine.2026.128351_bb0200","doi-asserted-by":"crossref","unstructured":"Wang CY, Chen YH, Fang C, Zhou MM, Xu HM, Jing CM, et al. Antibiotic resistance profiles and multidrug resistance patterns of Streptococcus pneumoniae in pediatrics: a multicenter retrospective study in mainland China. Medicine (Baltimore) 2019;98:e15942. doi:https:\/\/doi.org\/10.1097\/MD.0000000000015942.","DOI":"10.1097\/MD.0000000000015942"},{"key":"10.1016\/j.vaccine.2026.128351_bb0205","doi-asserted-by":"crossref","unstructured":"Kyaw MH, Lynfield R, Schaffner W, et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 2006;354(14):1455\u201363 doi:https:\/\/doi.org\/10.1056\/NEJMoa051642.","DOI":"10.1056\/NEJMoa051642"},{"key":"10.1016\/j.vaccine.2026.128351_bb0210","doi-asserted-by":"crossref","DOI":"10.1186\/s12887-025-05593-w","article-title":"Serotypes distribution and antibiotic susceptibility of Streptococcus pneumoniae strains: five-year surveillance results of post-PCV-13","volume":"25","author":"Atici","year":"2025","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.vaccine.2026.128351_bb0215","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-025-10672-5","article-title":"Serotype distribution of invasive pneumococcal disease in a tertiary children\u2019s hospital in Vietnam","volume":"25","author":"Do","year":"2025","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128351_bb0220","doi-asserted-by":"crossref","unstructured":"Adam HJ, Karlowsky JA, Baxter MR, Schellenberg J, Golden AR, Martin I, et al. Analysis of MDR in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011-2020. J Antimicrob Chemother 2023;78(Suppl 1):i i8-i16. doi:https:\/\/doi.org\/10.1093\/jac\/dkad065.","DOI":"10.1093\/jac\/dkad066"},{"key":"10.1016\/j.vaccine.2026.128351_bb0225","doi-asserted-by":"crossref","unstructured":"Diab-Casares L, Tormo-Palop N, Hernandez-Felices FJ, Artal-Munoz V, Floria-Baquero P, Martin-Rodriguez JL, et al. Predominant pneumococcal serotypes in isolates causing invasive disease in a Spanish region: an examination of their association with clinical factors, antimicrobial resistance, and vaccination coverage. J Clin Med 2025;14. doi:https:\/\/doi.org\/10.3390\/jcm14051612.","DOI":"10.3390\/jcm14051612"},{"key":"10.1016\/j.vaccine.2026.128351_bb0230","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-018-1109-4","article-title":"Resistance decay in individuals after antibiotic exposure in primary care: a systematic review and meta-analysis","volume":"16","author":"Bakhit","year":"2018","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2026.128351_bb0235","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1128\/AAC.45.10.2765-2770.2001","article-title":"Nasopharyngeal carriage of antimicrobial-resistant Streptococcus pneumoniae among young children attending 79 kindergartens and day care centers in Hong Kong","volume":"45","author":"Chiu","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2026.128351_bb0240","first-page":"370","article-title":"Nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae in healthy children","volume":"49","author":"Uzuner","year":"2007","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.vaccine.2026.128351_bb0245","article-title":"Prevalence and serotype distribution of nasopharyngeal carriage of Streptococcus pneumoniae in Vietnam: a systematic review and meta-analysis","volume":"66","author":"Tao","year":"2026","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.vaccine.2026.128351_bb0250","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s13052-025-02161-x","article-title":"Cell wall-inhibiting antibiotics resistance in Streptococcus pneumoniae causing invasive diseases: a global systematic review and meta-analysis in pediatric populations","volume":"51","author":"Alhusseini","year":"2025","journal-title":"Ital J Pediatr"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26001593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26001593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T22:30:50Z","timestamp":1783377050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26001593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":50,"alternative-id":["S0264410X26001593"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128351","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of and risk factors for antimicrobial resistance in pneumococcal disease in southern Ontario during the PCV13 era","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128351","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128351"}}